1921
Volume 89, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Global Program to Eliminate Lymphatic Filariasis (GPELF) guidelines call for using filarial antigen testing to identify endemic areas that require mass drug administration (MDA) and for post-MDA surveillance. We compared a new filarial antigen test (the Alere Filariasis Test Strip) with the reference BinaxNOW Filariasis card test that has been used by the GPELF for more than 10 years. Laboratory testing of 227 archived serum or plasma samples showed that the two tests had similar high rates of sensitivity and specificity and > 99% agreement. However, the test strip detected 26.5% more people with filarial antigenemia (124/503 versus 98/503) and had better test result stability than the card test in a field study conducted in a filariasis-endemic area in Liberia. Based on its increased sensitivity and other practical advantages, we believe that the test strip represents a major step forward that will be welcomed by the GPELF and the filariasis research community.

[open-access] This is an Open Access article distributed under the terms of the American Society of Tropical Medicine and Hygiene's Re-use License which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.13-0089
2013-07-10
2017-09-23
Loading full text...

Full text loading...

/deliver/fulltext/14761645/89/1/11.html?itemId=/content/journals/10.4269/ajtmh.13-0089&mimeType=html&fmt=ahah

References

  1. WHO, 2011. The Global Programme to Eliminate Lymphatic Filariasis: Progress Report 2000–2009 and Strategic Plan 2010–2020. Geneva: World Health Organization, 178.
  2. WHO, 2012. Global programme to eliminate lymphatic filariasis: progress report, 2011. Wkly Epidemiol Rec 87: 346356.
  3. Ottesen EA, Duke BO, Karam M, Behbehani K, , 1997. Strategies and tools for the control/elimination of lymphatic filariasis. Bull World Health Organ 75: 491503.
  4. Michael E, Bundy DA, Grenfell BT, , 1996. Re-assessing the global prevalence and distribution of lymphatic filariasis. Parasitology 112: 409428.[Crossref]
  5. Weil GJ, Ramzy RM, , 2007. Diagnostic tools for filariasis elimination programs. Trends Parasitol 23: 7882.[Crossref]
  6. More SJ, Copeman DB, , 1990. A highly specific and sensitive monoclonal antibody-based ELISA for the detection of circulating antigen in bancroftian filariasis. Trop Med Parasitol 41: 403406.
  7. Weil GJ, Jain DC, Santhanam S, Malhotra A, Kumar H, Sethumadhavan KV, Liftis F, Ghosh TK, , 1987. A monoclonal antibody-based enzyme immunoassay for detecting parasite antigenemia in bancroftian filariasis. J Infect Dis 156: 350355.[Crossref]
  8. Forsyth KP, Spark R, Kazura J, Brown GV, Peters P, Heywood P, Dissanayake S, Mitchell GF, , 1985. A monoclonal antibody-based immunoradiometric assay for detection of circulating antigen in bancroftian filariasis. J Immunol 134: 11721177.
  9. Gass K, Beau de Rochars MV, Boakye D, Bradley M, Fischer PU, Gyapong J, Itoh M, Ituaso-Conway N, Joseph H, Kyelem D, Laney SJ, Legrand AM, Liyanage TS, Melrose W, Mohammed K, Pilotte N, Ottesen EA, Plichart C, Ramaiah K, Rao RU, Talbot J, Weil GJ, Williams SA, Won KY, Lammie P, , 2012. A multicenter evaluation of diagnostic tools to define endpoints for programs to eliminate bancroftian filariasis. PLoS Negl Trop Dis 6: e1479.[Crossref]
  10. WHO, 2011. Lymphatic Filariasis Transmission Assessment Surveys. Geneva: World Health Organization, 1100.
  11. Simonsen PE, Magesa SM, , 2004. Observations on false positive reactions in the rapid NOW filariasis card test. Trop Med Int Health 9: 12001202.[Crossref]
  12. Krolewiecki AJ, Ramanathan R, Fink V, McAuliffe I, Cajal SP, Won K, Juarez M, Di Paolo A, Tapia L, Acosta N, Lee R, Lammie P, Abraham D, Nutman TB, , 2010. Improved diagnosis of Strongyloides stercoralis using recombinant antigen-based serologies in a community-wide study in northern Argentina. Clin Vaccine Immunol 17: 16241630.[Crossref]
  13. Weil GJ, Malane MS, Powers KG, Blair LS, , 1985. Monoclonal antibodies to parasite antigens found in the serum of Dirofilaria immitis-infected dogs. J Immunol 134: 11851191.
  14. Supali T, Wibowo H, Ruckert P, Fischer K, Ismid IS, Purnomo Djuardi Y, Fischer P, , 2002. High prevalence of Brugia timori infection in the highland of Alor Island, Indonesia. Am J Trop Med Hyg 66: 560565.
  15. Ramzy RM, El Setouhy M, Helmy H, Ahmed ES, Abd Elaziz KM, Farid HA, Shannon WD, Weil GJ, , 2006. Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment. Lancet 367: 992999.[Crossref]
  16. Weil GJ, Kastens W, Susapu M, Laney SJ, Williams SA, King CL, Kazura JW, Bockarie MJ, , 2008. The impact of repeated rounds of mass drug administration with diethylcarbamazine plus albendazole on bancroftian filariasis in Papua New Guinea. PLoS Negl Trop Dis 2: e344.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.13-0089
Loading
/content/journals/10.4269/ajtmh.13-0089
Loading

Data & Media loading...

  • Received : 18 Feb 2013
  • Accepted : 27 Mar 2013

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error